.png/:/rs=w:1209,h:754){kind=logo}
Oyanalytika Inc.
Founded in 2021, Oyanalytika is a woman-owned company offering data analytics for clinical research and development.
About OYA
Our Mission
Oyanalytika offers expertise in designing, analyzing, and interpreting clinical studies. We specialize in providing regulatory support, designing intricate clinical and pre-clinical studies, and assisting data safety monitoring committees and institutional review boards. Our vast experience in targeted therapeutics and analyzing biomarkers enables us to effectively support these studies. Our main focus is on providing analytical and regulatory support for studies on COVID-19 vaccines and therapeutics, including next-generation solutions that address the rapid emergence of new variants globally.
Our Vision
Oya serves the patient populations of the diseases it investigates by making our experience available to improve our collection, interpretation, and communication of complex data. Our expertise sustains the design, analyses, and implementation of clinical studies, including drug and vaccine development. We have a strong focus on target discovery for complex diseases.
Our Expertise
Our expertise in high-dimensional analytics provides us with unique knowledge that combines complex data analytics with clinical relevance in drug discovery and regulatory approval.
Dr. Ena Bromley has been involved in over 400 preclinical, clinical, and device studies across a variety of diseases, with a particular early focus on oncology, neurodegenerative diseases, and infectious diseases. This has expanded to include complex clinical trial design consulting across multiple disease modalities.
Dr. Gene Olinger has over two decades of experience in discovery, non-clinical, and pre-clinical translational research that bridges the gap between the laboratory and the clinic. He has overseen projects adhering to GLP, GMP, and ISO quality standards in BSL1 to BSL4. His experience spans across infectious diseases, diagnostics (IVD) development, vaccines, and therapeutics, including small molecule anti-infectives and biologics. More recently, he has been involved in chronic disease, oncology, and translational science for optimal health.
Our skilled staff specializes in a wide range of fields, including program management, quality control and standardization, business analysis, planning (horizon scanning and technology analysis), supply and logistics planning, statistics, analytics, and programming.